Associations between both genetic and environmental biomarkers and lung cancer: Evidence of a greater risk of lung cancer in women smokers

Carcinogenesis

Volumn 19, Issue 11, 1998, Pages 1949-1953

  Tang, D L ^a   Rundle, A ^a   Warburton, D ^a   Santella, R M ^a   Tsai, W Y ^a   Chiamprasert, S ^a   Hsu, Y Z ^a   Perera, F P ^a  

^a Div of Environ Health Sciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE;

ARTICLE; CANCER REGISTRY; CANCER RISK; COLOMBIA; CONTROLLED STUDY; DNA ADDUCT; ENVIRONMENTAL FACTOR; FEMALE; GENETIC MARKER; GENOTYPE; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SISTER CHROMATID EXCHANGE; SMOKING;

EID: 0031721438     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.11.1949     Document Type: Article

References (41)

1. Pero, R.W., Seidegard, J. and Miller D.G. (1986) Development of biochemical markers sensitive to ecogenetic variation and their use in assessing risk from genotoxic exposures. Prog. Clin. Biol. Res., 209B, 225-235.
2. Mannervik, B. and Danielson, U. (1988) Glutathione transferase - structure and catalytic activity. CRC Crit. Rev. Biochem., 23, 283-337.
3. Ketterer, B. (1988) Protective role of glutathione and glutathione transferase in mutagenesis and carcinogenesis. Mutat. Res., 202, 343-361.
4. Robertson, I.G.C, Guthenberg, C., Mannervik, B. and Jernstrom, B. (1986) Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutathione with 7B.8,α-dihydroxy-9a. 10,α-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Cancer Res., 46, 2220-2224.
5. Seidegard, J., Pero, R. and Stille, B. (1989) Identification of the trans-stilbene oxide-active glutathione transferase in human mononuclear leukocytes and in liver as GST1. Biochem. Genet., 27, 253-261.
6. Bell, D.A., Taylor, J.A., Paulson, D.F., Robertson, C.N., Mohler, J.L. and Lucier, G.W. (1993) Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
7. Seidegard, J., Vorachek, W.R., Pero, R.W. and Pearson, W.R. (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl Acad. Sci. USA. 85, 7293-7297.
8. Seidegard, J., Pero, R.W., Markowitz, M.M., Roush, G., Miller, D.G. and Beattie, E.J. (1990) Isoenzyme(s) of glutathione transferase (class mu) as a marker for the susceptibility to lung cancer: A follow-up study. Carcinogenesis, 11, 33-36.
9. Nakachi, K., Imai, K., Hayashi, S., Watanabe, J. and Kawajiri, K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res., 51, 5177-5180.
10. Zhong, S., Howie, A.E. Ketterer, B., Taylor, J., Hayes, J.D., Beckett, G.J., Wathen, C.G., Wolf, C.R. and Spurr, N.K. (1991) Glutathione S-transferase mu locus: Use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis, 9, 1533-1537.
11. Bell, D.A., Thompson, C.L., Taylor, J., Clark, G., Miller, C.R., Perera, F., Hsieh, L. and Lucier, G.W. (1992) Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: Application to glutathione transferase. Environ. Health Persp., 98, 113-117.
12. Brockmöller, J., Kerb, R., Drakoulis, N., Nitz, M. and Roots I. (1993) Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and O in lung cancer patients and controls. Cancer Res., 53, 1004-1011.
13. Nazar-Stewart, V., Motulsky, A.G., Eaton, D.L., White, E., Hornung, S.K., Leng, Z.-T., Stapleton, P. and Weiss, N. (1993) The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53, 2313-2318.
14. Hirvonen, A. (1995) Genetic factors in individual responses to environmental exposures. J. Occup. Environ. Med., 37, 37-43.
15. Pelin, K., Hirvonen, A., Taavitsainen, M. and Linnainmaa, K. (1995) Cytogenetic response to asbestos fibers in cultured human primary mesothelial cells from 10 different donors. Mutat. Res., 334, 225-233.
16. McWilliams, J.E., Sanderson, B.J.S., Harris, E.L., Richert-Boe, K.E. and Henner, W.D. (1995) Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 4, 589-594.
17. van Poppel, G., de Vogel, N., van Balderen, P.J. and Kok, F.J. (1992) Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme μi. Carcinogenesis, 13, 303-305.
18. Tang, D.L., Santella, R.M., Blackwood, A. et al. (1995) A case-control molecular epidemiological study of lung cancer. Cancer Epidemiol. Biomarkers Prev., 4, 341-346.
19. 6-alkylguanine ratio in DNA with carcinogenic potency in rodents. Mutat. Res., 110, 181-219.
20. Pelkonen, O., Karki, N.T. and Sotaniemi, B.A. (1980) Determination of carcinogen-activating enzymes in the monitoring of high-risk groups. In Davis, W., Harrap, K.R. and Stathopoulos, G. (eds) Human Cancer: Its Characterization and Treatment. Excerpta Medica, Amsterdam, pp. 48-57.
21. Lutz, W.K. (1979) In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis. Mutat. Res., 65, 289-356.
22. Lutz, W.K. (1986) Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens. J. Cancer Res. Clin. Oncol., 112, 85-91.
23. Carrano, A.V. and Moore, D.H. (1982) The rationale and methodology for quantifying sister chromatid exchange frequency in humans. In Heddle, J.A. (ed.) Mutagenicity: New Horizons in Genetic Toxicology. Academic Press, New York, pp. 267-304.
24. Garner, R.C., Cuzick, J., Jenkins, D., Phillips, D.H., Hewer, A., King, M.M. and Routledge, M.N. (1990) Linear relationship between DNA adducts in human lung and cigarette smoking. In Vainio, H., Sorsa, M. and McMichael, A.J. (eds) Complex Mixtures and Cancer Risk. IARC Scientific Publications, IARC, Lyon, pp. 421-426.
25. Hulka, B.S., Griffith, J.D. and Wilcosky, T.C. (1990) Biologic Markers in Epidemiology. Oxford University Press, New York.
26. Perera, F.P., Mayer, J., Jaretzki, A. et al. (1989) Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls. Cancer Res., 49, 4446-4451.
27. Santella, R.M., Hemminki, K., Tang, D.L. et al. (1993) Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and urinary 1-hydroxypyrene in foundry workers. Cancer Epidemiol. Biomarkers Prev., 2, 59-62.
28. Rothman, K.J. (1986) Modern Epidemiology. Little, Brown and Company, Boston, MA.
29. Alexandrie, A.K., Sundberg, M.I., Seidegard, J., Tornling, G. and Rannus, A. (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis, 15, 1785-1790.
30. Risch, H.A., Howe, G.R., Jain, M., Burch, J.D., Holowaty, E.J. and Miller, A.B. (1993) Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am. J. Epidemiol., 138, 281-293.
31. Zang, E.A. and Wynder, E.L. (1994) Cumulative tar exposure: A new index for estimating lung cancer risk among cigarette smokers. Cancer, 70, 69-76.
32. Ryberg, D., Hewer, A., Phillips, D.H. and Haugen, A. (1994) Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res., 54, 5801-5803.
33. Guinee, D.G. Jr, Travis, W.D., Trivers, G.E. et al. (1995) Gender comparisons in human lung cancer: Analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis, 16, 993-1002.
34. Cheng, T.J., Christiani, D.C., Wiencke, J.K., Wain, J.C., Xu, X. and Kelsey, K.T. (1995) Comparison of sister chromatid exchange frequency in peripheral lymphocytes in lung cancer cases and controls. Mutat. Res., 348, 75-82.
35. Rothman, N., Shields, P.G., Poirier, M.C., Harrington, A.M., Ford, D.P. and Strickland, P.T. (1995) The impact of glutathione S-transferase M1 and cytochrome P450 1A1 genotypes on white blood cell polycyclic aromatic hydrocarbon-DNA adduct levels in humans. Mol. Carcinogen., 14, 63-68.
36. Ichiba, M., Hagmar, L., Rannug, A., Hogstedt, B., Alexandrie, A.K., Carstensen, U. and Hemminki, K. (1994) Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST in chimney sweeps. Carcinogenesis, 15, 1347-1352.
37. Grinberg-Funes, R.A., Singh, V.N., Perera, F.P., Bell, D.A., Young, T.L., Dickey, C., Wang, L.W. and Santella, R.M. (1994) Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and glutathione S-transferase Ml genotype. Carcinogenesis, 15, 2449-2454.
38. Shields, P.G., Caporaso, N.E., Falk, R.T., Sugimura, H., Trivers, G.E., Trump, B.F., Hoover, R.N., Weston, A. and Harris, C.C. (1993) Lung cancer, race and a CYP1A1 genetic polymorphism. Cancer Epidemiol. Biomarkers Prev., 2, 481-485.
39. Wiencke, J.K., Kelsey, K.T., Lamela, R.A. and Toscano, W.A. Jr (1990) Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res., 50, 1585-1590.
40. van Poppel, G., Verhagen, H., van't Veer, P. and van Bladen, J. (1993) Markers for cytogenetic damage in smokers: associations with plasma antioxidants and glutathione S-transferase μ. Cancer Epidemiol. Biomarkers Prev., 2, 441-447.
41. Cheng, T.J., Christiani, D.C., Xu. X., Wain, J.C., Wiencke, J.K. and Kelsey, K.T. (1995) Glutathione S-transferase u genotype, diet and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol. Biomarkers Prev., 4, 535-542.